VP-001

N/A

Report date: 2025/03/04 20:00:11
NME

Base Information

Drug NameVP-001
Drug Alias NameVP-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsRetinal DystrophiesRetinal DiseasesRetinitis Pigmentosa +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPYC Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesPYC Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsRetinal DystrophiesRetinal DiseasesRetinitis Pigmentosa +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A